Video

Q&A With Marco Carbone From University of Cambridge: Developing A Scoring System To Predict Primary Biliary Cholangitis

Author(s):

When treating liver disease every advantage can help doctors get their patients the care they need before the condition progresses further. A recent study looked at the potential of developing a scoring system to look at risks for this patient population.

When treating liver disease every advantage can help doctors get their patients the care they need before the condition progresses further. A recent study looked at the potential of developing a scoring system to look at risks for this patient population.

Marco Carbone, MD, from the University of Cambridge discussed why the system was being developed and what it could mean to patient care during the annual Liver Meeting in San Francisco.

Related Videos
Chari Cohen, DrPH, MPH | Credit: LinkedIn
Zoi Papalamprakopoulou, MD | Credit: Papalamprakopoulou on LinkedIn
Mitchell Schiffman, MD | Credit: Bon Secours Virginia
Mitchell Shiffman, MD | Credit: Bon Secours
Stephen Congly, MD | Credit: University of Calgary
Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH
Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH
Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH
Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH
Unmet Needs in HBV Thumbnail featuring Nancy Reau, MD, Andrew Talal, MD, and Chari Cohen, DrPH, MPH
© 2024 MJH Life Sciences

All rights reserved.